| Size | Price | |
|---|---|---|
| Other Sizes |
| Targets |
- Trans-Anethole binds to estrogen receptor (ER) and exerts estrogenic activity, with an EC50 of 12.5 μM in recombinant yeast estrogen screen[1]
- Trans-Anethole regulates key enzymes of carbohydrate metabolism, including hexokinase (HK), phosphofructokinase (PFK), and glucose-6-phosphatase (G6Pase); it increases HK and PFK activities by 35% and 42%, respectively, and decreases G6Pase activity by 28% in streptozotocin (STZ)-induced diabetic rats[5] - Trans-Anethole inhibits the growth of Aspergillus flavus (fungal target: cell membrane integrity), with a minimum inhibitory concentration (MIC) of 0.5 mg/mL[7] |
|---|---|
| ln Vitro |
- Estrogenic activity in recombinant yeast: Trans-Anethole induced β-galactosidase activity in ER-transfected recombinant yeast cells in a concentration-dependent manner. At 12.5 μM (EC50), the enzyme activity was 50% of the maximum response; at 100 μM, the activity was 8.2-fold higher than the blank control, confirming its estrogenic activity[1]
- Cytotoxic and xenoestrogenic effects on cells: In in vitro biotransformation experiments with isolated rat hepatocytes, 100 μM Trans-Anethole was metabolized to products that increased the proliferation rate of MCF-7 human breast cancer cells by 25% (xenoestrogenic effect). Without biotransformation, 100 μM Trans-Anethole had no significant effect on MCF-7 proliferation. Additionally, 200 μM Trans-Anethole reduced the viability of isolated rat hepatocytes by 18% after 24-hour incubation (cytotoxicity)[2] - Antifungal activity against Aspergillus flavus: Trans-Anethole inhibited spore germination and mycelial growth of Aspergillus flavus in vitro. At 0.5 mg/mL (MIC), it completely inhibited spore germination; at 1.0 mg/mL, it suppressed mycelial growth by 85% and reduced aflatoxin production by 90% compared to the control[7] - Regulation of carbohydrate-metabolizing enzymes: In liver homogenates from STZ-induced diabetic rats, Trans-Anethole (100 μg/mL, in vitro incubation) increased HK activity by 30% and PFK activity by 38%, while decreasing G6Pase activity by 25% compared to the diabetic control homogenate[5] |
| ln Vivo |
- Protective effect in experimental thrombosis: Male Wistar rats were subjected to ferric chloride-induced carotid artery thrombosis. Oral administration of Trans-Anethole at 50 mg/kg and 100 mg/kg for 7 days prior to thrombosis induction prolonged the time to complete occlusion by 45% and 68%, respectively, compared to the control group. It also reduced thrombus weight by 32% (50 mg/kg) and 55% (100 mg/kg) and decreased plasma levels of thromboxane B2 (TXB2) by 28% (100 mg/kg)[4]
- Antihyperglycemic effect in diabetic rats: STZ-induced diabetic rats were treated with Trans-Anethole (20 mg/kg and 40 mg/kg, oral gavage) daily for 21 days. The 40 mg/kg dose reduced fasting blood glucose levels by 52% compared to the diabetic control group. It also normalized carbohydrate-metabolizing enzymes: HK activity in liver increased by 42%, PFK by 38%, and G6Pase decreased by 28%. Additionally, serum insulin levels increased by 35% in the 40 mg/kg group[5] - Anti-fertility activity in rats: Male albino rats were administered Trans-Anethole (100 mg/kg, oral) daily for 60 days. Sperm count decreased by 65%, sperm motility by 58%, and serum testosterone levels by 42% compared to the control group. Histological examination showed reduced seminiferous tubule diameter and germ cell count in the testes[6] |
| Enzyme Assay |
- Estrogen receptor-mediated β-galactosidase activity assay: Recombinant yeast cells transfected with human ER and β-galactosidase reporter gene were inoculated into culture medium containing different concentrations of Trans-Anethole (0.1–200 μM). The cells were incubated at 30°C for 24 hours, then lysed with lysis buffer. β-galactosidase activity was measured by adding o-nitrophenyl-β-D-galactopyranoside (ONPG) substrate, incubating at 37°C for 30 minutes, and reading absorbance at 420 nm. The EC50 was calculated from the dose-response curve[1]
- Carbohydrate-metabolizing enzyme activity assay: Liver tissue from STZ-induced diabetic rats was homogenized in ice-cold buffer. The homogenate was centrifuged at 10,000 × g for 15 minutes, and the supernatant was used for enzyme assays. For HK activity: the reaction mixture contained supernatant, glucose, ATP, and NADP+; absorbance was measured at 340 nm to monitor NADPH formation. For G6Pase activity: the mixture contained supernatant and glucose-6-phosphate; released phosphate was measured using ammonium molybdate reagent at 620 nm. PFK activity was measured by monitoring NADH oxidation at 340 nm in a reaction mixture with supernatant, fructose-6-phosphate, ATP, and NADH-linked enzymes[5] - Fungal enzyme inhibition assay (for Aspergillus flavus ): Aspergillus flavus mycelia were homogenized in buffer and centrifuged to obtain crude enzyme extract. The extract was incubated with Trans-Anethole (0.25–2.0 mg/mL) and cell wall synthesis-related enzyme substrates (e.g., UDP-glucose). Enzyme activity was measured by quantifying remaining substrate using HPLC. At 0.5 mg/mL Trans-Anethole, cell wall synthase activity was inhibited by 60%[7] |
| Cell Assay |
- Recombinant yeast estrogen screen assay: ER-transfected yeast cells were seeded into 96-well plates with medium containing Trans-Anethole (0.1–200 μM). After 24-hour incubation at 30°C, cell viability was checked by trypan blue exclusion (to ensure no cytotoxicity), and β-galactosidase activity was assayed as described in Enzyme Assay. 17β-Estradiol was used as a positive control[1]
- MCF-7 cell proliferation assay: MCF-7 cells were seeded into 96-well plates at 5×10³ cells/well. After 24-hour adherence, the medium was replaced with medium containing biotransformed Trans-Anethole (25–200 μM, obtained from rat hepatocyte metabolism) or non-biotransformed Trans-Anethole. After 72-hour incubation, cell proliferation was measured by MTT assay (absorbance at 570 nm). The proliferation rate was calculated relative to the control group[2] - Isolated rat hepatocyte assay: Hepatocytes were isolated from male Wistar rats by collagenase perfusion and seeded into 6-well plates. After 4-hour attachment, Trans-Anethole (50–200 μM) was added. After 24-hour incubation, cell viability was measured by lactate dehydrogenase (LDH) release assay (absorbance at 490 nm) and trypan blue staining. The culture medium was collected to analyze Trans-Anethole metabolites by HPLC[2] - Aspergillus flavus spore germination assay: Aspergillus flavus spores were suspended in potato dextrose broth (PDB) containing Trans-Anethole (0.125–2.0 mg/mL). The suspension was incubated at 28°C, and spore germination was observed under a microscope at 6, 12, and 24 hours. Germination rate was calculated as the percentage of spores with germ tubes longer than the spore diameter[7] |
| Animal Protocol |
- Experimental thrombosis model (rat): Male Wistar rats (200–220 g) were divided into 3 groups (n=6/group): control (saline), Trans-Anethole 50 mg/kg, and Trans-Anethole 100 mg/kg. Trans-Anethole was dissolved in 0.5% carboxymethyl cellulose (CMC) and administered by oral gavage daily for 7 days. On day 8, the left carotid artery was exposed, and a filter paper soaked in 40% ferric chloride was applied to the artery for 10 minutes to induce thrombosis. Blood flow was monitored using a Doppler flowmeter to record time to complete occlusion. After sacrifice, the artery was excised to weigh the thrombus[4]
- STZ-induced diabetic rat model: Male Sprague-Dawley rats (180–200 g) were rendered diabetic by a single intraperitoneal injection of STZ (60 mg/kg, dissolved in citrate buffer, pH 4.5). After 7 days, rats with fasting blood glucose >250 mg/dL were selected and divided into 3 groups (n=6/group): diabetic control (saline), Trans-Anethole 20 mg/kg, and Trans-Anethole 40 mg/kg. Trans-Anethole was dissolved in 0.5% CMC and given by oral gavage daily for 21 days. Fasting blood glucose was measured weekly using a glucometer. At the end of the study, rats were sacrificed, and liver tissue was collected for enzyme assays; serum was collected for insulin measurement[5] - Anti-fertility model (rat): Male albino rats (180–200 g) were divided into 2 groups (n=5/group): control (saline) and Trans-Anethole 100 mg/kg. Trans-Anethole was dissolved in corn oil and administered by oral gavage daily for 60 days. Every 15 days, blood samples were collected from the tail vein to measure serum testosterone levels by ELISA. After 60 days, rats were sacrificed; testes were excised for histological examination, and epididymides were collected to count sperm and assess motility[6] |
| ADME/Pharmacokinetics |
Absorption, Distribution and Excretion
/ Biotransformation of Anethole / ...Anethole acid ... is the main urinary metabolite. ... Quantitative recovery is possible with the administered dose. Trans-anethole is one of four food additives studied and found to be absorbed primarily from the digestive tract via passive diffusion. Absorption kinetics depend in part on the differences in the compound's lipid solubility coefficient. ...Studies were conducted in rabbits and rats after intravenous and oral administration of trans-anethole used in the preparation of anise-flavored alcoholic beverages. Regardless of the route of administration, the substance was rapidly excreted from the animals. After intravenous injection, the substance was mainly concentrated in the liver, lungs, and brain tissue; after oral administration, most of the substance remained in the stomach. Trans-anethole is one of the compounds mainly absorbed from the digestive tract via passive diffusion. Metabolites of anethole in rats have been identified and determined. Most urinary metabolites were also detected in bile. Metabolism/Metabolites Anethole generates p-propenylphenol in rabbits, mice, guinea pigs, and dogs. Anethole is converted to p-propenylphenol in rats. (Data from table) Anethole is converted to anisic acid in humans, rabbits, and rats. Anethole is converted to p-methoxycinnamoyl alcohol in rats. Oxidative demethylation to p-hydroxypropenylbenzene and p-hydroxycinnamoyl acid is the main biotransformation pathway of anethole. Compared with allyl compounds, cinnamoyl derivatives with propenyl substituents are metabolized more extensively; and β-oxidative metabolism also occurs. - Biotransformation in rat hepatocytes: Isolated rat hepatocytes metabolized trans-anenethole (100 μM) into two major metabolites (identified by HPLC-MS). The half-life of trans-anetinoside in hepatocyte culture was 4.2 hours, and 65% of the parent compound was metabolized within 12 hours [2]. Oral absorption in rats: After oral administration of trans-anetinoside (40 mg/kg) to diabetic rats, the peak plasma concentration (Cmax) was 1.8 μg/mL, the time to peak concentration was 1.5 hours (Tmax), and the apparent volume of distribution (Vd) was 25 L/kg. The plasma half-life (t1/2) was 3.8 hours [5]. |
| Toxicity/Toxicokinetics |
Interactions
The average sleep time of mice treated with 50 mg/kg sodium pentobarbital approximately doubled after administration of 20 and 50 mg of certain compounds; the activity of anethole was lower. - Hepatotoxicity: trans-anenethole exhibited dose-dependent cytotoxicity in isolated rat hepatocytes. At 100 μM, LDH release increased by 12% (mild toxicity); at 200 μM, LDH release increased by 35%, and the proportion of trypan blue positive cells reached 22% (moderate toxicity) [2] - Reproductive toxicity: Reproductive toxicity was observed in male rats after oral administration of trans-anenethole (100 mg/kg) for 60 days, including decreased sperm count (65%), motility (58%) and testosterone levels (42%), but no significant changes in body weight or liver and kidney weight (indicating no systemic toxicity) [6] |
| References | |
| Additional Infomation |
Anethole is a white crystalline or liquid substance with the aroma and sweetness of fennel oil. (NTP, 1992)
Anethole is a monomethoxybenzene with a structure in which methoxybenzene is substituted at the 4-position with a prop-1-en-1-yl group. It is a plant metabolite. Anethole has been reported to be found in apples, asarums, and other organisms with relevant data. Anethole is a metabolite found or produced in Saccharomyces cerevisiae. -trans-anenethole is a major component of essential oils from fennel, anise (Foeniculum vulgare), and star anise (Illicium verum) [1,4,7]. -trans-anenethole is widely used in the food industry as a flavoring agent and in the cosmetics industry as a flavoring ingredient, and its food use is generally considered safe (GRAS) [3]. - Estrogen-active trans-anisone exerts its effects by binding to estrogen receptors (ER), activating estrogen-responsive genes (such as β-galactosidase in recombinant yeast) [1] - The antithrombotic effect of trans-anisone is associated with decreased TXB2 levels, which inhibit platelet aggregation and thrombus formation [4] |
| Molecular Formula |
C10H12O
|
|---|---|
| Molecular Weight |
148.2017
|
| Exact Mass |
148.089
|
| CAS # |
4180-23-8
|
| Related CAS # |
26795-32-4
|
| PubChem CID |
637563
|
| Appearance |
White to yellow <20°C powder,>21°C liquid
|
| Density |
0.9875
|
| Boiling Point |
234-237ºC
|
| Melting Point |
23ºC
|
| Flash Point |
90ºC
|
| Index of Refraction |
1.559-1.562
|
| LogP |
2.728
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
1
|
| Rotatable Bond Count |
2
|
| Heavy Atom Count |
11
|
| Complexity |
121
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
O(C([H])([H])[H])C1C([H])=C([H])C(/C(/[H])=C(\[H])/C([H])([H])[H])=C([H])C=1[H]
|
| InChi Key |
RUVINXPYWBROJD-ONEGZZNKSA-N
|
| InChi Code |
InChI=1S/C10H12O/c1-3-4-9-5-7-10(11-2)8-6-9/h3-8H,1-2H3/b4-3+
|
| Chemical Name |
1-methoxy-4-[(E)-prop-1-enyl]benzene
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~100 mg/mL (~674.76 mM)
H2O : ~1 mg/mL (~6.75 mM) |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (16.87 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (16.87 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (16.87 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. Solubility in Formulation 4: 50 mg/mL (337.38 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.7476 mL | 33.7382 mL | 67.4764 mL | |
| 5 mM | 1.3495 mL | 6.7476 mL | 13.4953 mL | |
| 10 mM | 0.6748 mL | 3.3738 mL | 6.7476 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.